Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01084252
Title Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sanofi
Indications

acute myeloid leukemia

multiple myeloma

B-cell lymphoma

chronic lymphocytic leukemia

B-cell adult acute lymphocytic leukemia

Therapies

Isatuximab

Dexamethasone + Isatuximab

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | BEL

Facility Status City State Zip Country Details
Investigational Site Number 840003 Scottsdale Arizona 85054 United States Details
Investigational Site Number 840005 San Francisco California 94117 United States Details
Investigational Site Number 840009 Atlanta Georgia 30322 United States Details
Investigational Site Number 840010 Chicago Illinois 60637 United States Details
Investigational Site Number 840022 Ann Arbor Michigan 48109-0759 United States Details
Investigational Site Number 840027 Detroit Michigan 48201 United States Details
Investigational Site Number 840018 Rochester Minnesota 55905 United States Details
Investigational Site Number 840013 Saint Louis Missouri 63110 United States Details
Investigational Site Number 840011 Hackensack New Jersey 07601 United States Details
Investigational Site Number 840014 New York New York 10021 United States Details
Investigational Site Number 840016 Durham North Carolina 27707 United States Details
Investigational Site Number 840004 Cincinnati Ohio 45267-0542 United States Details
Investigational Site Number 840001 Nashville Tennessee 37232 United States Details
Investigational Site Number 840002 Salt Lake City Utah 84112-5550 United States Details
Investigational Site Number 840012 Seattle Washington 98109 United States Details
Investigational Site Number 840017 Milwaukee Wisconsin 53226 United States Details
Investigational Site Number 032002 Caba C1181ACH Argentina Details
Investigational Site Number 032003 Capital Federal C1425ASS Argentina Details
Investigational Site Number 032001 Ciudad De Buenos Aires C1426ANZ Argentina Details
Investigational Site Number 056001 Antwerpen 2060 Belgium Details
Investigational Site Number 076001 Barretos 14784-400 Brazil Details
Investigational Site Number 076003 Porto Alegre 90470-340 Brazil Details
Investigational Site Number 076004 Rio De Janeiro 22793-080 Brazil Details
Investigational Site Number 076002 Sao Paulo 04537-081 Brazil Details
Investigational Site Number 152001 Temuco 4810469 Chile Details
Investigational Site Number 246001 Helsinki 00029 Finland Details
Investigational Site Number 246002 Turku 20521 Finland Details
Investigational Site Number 250003 Nantes Cedex 01 44093 France Details
Investigational Site Number 250004 Pierre Benite 69310 France Details
Investigational Site Number 250001 Toulouse Cedex 9 31059 France Details
Investigational Site Number 300001 Athens 11528 Greece Details
Investigational Site Number 376004 Jerusalem 91120 Israel Details
Investigational Site Number 376002 Tel Hashomer 52621 Israel Details
Investigational Site Number 380001 Bologna 40138 Italy Details
Investigational Site Number 380002 Torino 10126 Italy Details
Investigational Site Number 484001 Monterrey 64460 Mexico Details
Investigational Site Number 484003 San Luis Potosi 78419 Mexico Details
Investigational Site Number 604001 Arequipa Peru Details
Investigational Site Number 604002 Lima LIMA 34 Peru Details
Investigational Site Number 643002 Moscow 125284 Russian Federation Details
Investigational Site Number 643003 Novosibirsk 630087 Russian Federation Details
Investigational Site Number 643001 Petrozavodsk 185019 Russian Federation Details
Investigational Site Number 643004 Saint-Petersburg 194291 Russian Federation Details
Investigational Site Number 724007 Badalona 08916 Spain Details
Investigational Site Number 724005 Barcelona 08036 Spain Details
Investigational Site Number 724004 Madrid 28041 Spain Details
Investigational Site Number 724002 Pamplona 31008 Spain Details
Investigational Site Number 724001 Salamanca 37007 Spain Details
Investigational Site Number 724008 Sevilla 41013 Spain Details
Investigational Site Number 724006 Valencia 46017 Spain Details
Investigational Site Number 792002 Ankara 06200 Turkey Details
Investigational Site Number 792005 Ankara 06500 Turkey Details
Investigational Site Number 792001 İstanbul Turkey Details
Investigational Site Number 792004 Samsun 55139 Turkey Details
Investigational Site Number 804001 Kyiv 04112 Ukraine Details
Investigational Site Number 804004 Vinnitsya 21018 Ukraine Details
Investigational Site Number 804002 Zaporizhzhya 69600 Ukraine Details
Investigational Site Number 826001 Nottingham NG5 1PB United Kingdom Details
Investigational Site Number 826002 Southampton SO16 6YD United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field